Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet.
Jack A SyagePeter H R GreenChaitan KhoslaDaniel C AdelmanJennifer A Sealey-VoyksnerJoseph A MurrayPublished in: GastroHep (2019)
Although this study was not powered to definitively establish the benefit of latiglutenase in seropositive CD patients, such patients appear to show symptomatic and QOL benefit from using latiglutenase with meals.